-
Functional Areas
- Audit and Investigations
-
Capacity development and transition, strengthening systems for health
- A Strategic Approach to Capacity Development
- Capacity Development and Transition - Lessons Learned
- Capacity development and Transition Planning Process
- Capacity Development and Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Functional Capacities
- Interim Principal Recipient of Global Fund Grants
- Legal and Policy Enabling Environment
- Overview
- Resilience and Sustainability
- Transition
-
Financial Management
- CCM Funding
- Grant Closure
- Grant Implementation
- Grant-Making and Signing
- Grant Reporting
- Overview
- Sub-recipient Management
-
Grant closure
- Overview
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
- Terminology and Scenarios for Grant Closure Process
- Human resources
- Human rights, key populations and gender
-
Legal Framework
- Agreements with Sub-sub-recipients
- Amending Legal Agreements
- Implementation Letters and Management Letters
- Language of the Grant Agreement and other Legal Instruments
- Legal Framework for Other UNDP Support Roles
- Other Legal and Implementation Considerations
- Overview
- Project Document
- Signing Legal Agreements and Requests for Disbursement
-
The Grant Agreement
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Conditions
- Grant Confirmation: Face Sheet
- Grant Confirmation: Limited Liability Clause
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation
- UNDP-Global Fund Grant Regulations
- Monitoring and Evaluation
- Principal Recipient Start-Up
-
Procurement and Supply Management
- Development of List of Health Products and Procurement Action Plan
- Distribution and Inventory Management
- Overview
- Price and Quality Reporting (PQR) System
- Procurement of Non-health Products and Services
- Procurement of Pharmaceutical and Other Health Products
- Quality Control
- Rational use of Medicines and Pharmacovigilance Systems
- Strengthening of PSM Services and Risk Mitigation
- UNDP Health PSM Roster
- UNDP Quality Assurance Policy and Plan
-
Reporting
- Communicating Results
- Grant Performance Report
- Overview
- Performance-based Funding and Disbursement Decision
- PR and Coordinating Mechanism (CM) Communication and Governance
- Reporting to the Global Fund
- UNDP Corporate Reporting
-
Risk Management
- Common Risks Identified in Global Fund Programmes
- Global Fund Risk Management
- Introduction to Risk Management
- Overview
- Risk Management in High Risk Environments
- Risk Management in UNDP-managed Global Fund Grants
- Risk management in UNDP
- UNDP Risk Management in the Global Fund Portfolio
- Sub-Recipient Management
Non-compliance and Corrective Measures
There are two possible ways in which a Principal Recipient (PR) can breach the Grant Agreement by not complying with the Global Fund Quality Assurance (QA) Policy:
Level 1 non-compliance (no notification)
A PR has failed to send notifications required for the procurement of ERP-recommended products. However, the products procured complied with the QA policy.
Corrective measures for Level 1 non-compliance
After a Principal Recipient (PR) fails, for the first time, to send a notification for the procurement of a product that does not comply with Category A or Category B for a specific grant, the Global Fund will send the PR a warning letter. If the PR again fails to send notification for the same grant, the Global Fund may only disburse funds for pharmaceutical products directly to a procurement agent or a supplier for the remaining period of the Grant Agreement.
Level 2 non-compliance (non-compliant procurement)
A PR has failed to send notifications required for the procurement of ERP-recommended products, and the products procured do not comply with the QA policy.
Corrective measures for Level 2 non-compliance
If the PR, using grant funds, procures products that do not comply with the QA policy:
- the PR must refund to the Global Fund the amount paid for the non-compliant products, and the Secretariat may deduct the amount from future disbursements under the grant, or from the amount recommended for the next grant, if the PR has applied for continued funding; and during period of the Grant Agreement, the Global Fund will disburse all funds for pharmaceutical products directly to a procurement agent or a supplier.
PRs with a history of Level 2 non-compliance must provide evidence assuring the Global Fund of future compliance in order to obtain approval of the next grant. After a second instance of non-compliance, the Global Fund may stop funding for pharmaceutical products. In severe cases, the grant may be suspended or terminated.
Loading resources
